Showing results (851-860 of 901) with videos related to

Sort By:
Pageof 91
International Journal of Clinical Oncology|July 29, 2019
Tandem high-dose chemotherapy with topotecan-thiotepa-carboplatin and melphalan-etoposide-carboplatin regimens for pediatric high-risk brain tumorsJung Yoon Choi, Hyoung Jin Kang, Kyung Taek Hong, et al.
Cancer Chemotherapy and Pharmacology|October 13, 2009
Survival benefit from ovarian metastatectomy in colorectal cancer patients with ovarian metastasis: a retrospective analysisSu Jin Lee, Jeeyun Lee, Ho Yeong Lim, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 28, 2020
A multicenter phase II randomized trial of durvalumab (MEDI-4736) versus physician's choice chemotherapy in recurrent ovarian clear cell adenocarcinoma (MOCCA)Natalie Yl Ngoi, Valerie Heong, Samuel Ow, et al.
Nature Communications|April 24, 2026
High-strength and high-modulus silicon monoxide for high-energy-density and fast-charging lithium-ion batteriesMinjun Je, Yeong Hun Choi, Seung Hyun Jeong, et al.
Taehan Yongsang Uihakhoe Chi|October 14, 2022
[Korean Clinical Practice Guidelines for Adverse Reactions to Intravenous Iodinate and MRI-Gadolinium Contrast Agents: Revised Clinical Consensus and Recommendations (3rd Edition, 2022)]Se Won Oh, So Young Park, Hwan Seok Yong, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 20, 2021
Phase 3, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer: ENGOT-en9/LEAP-001Christian Marth, Rafal Tarnawski, Alexandra Tyulyandina, et al.
Cancer Research|February 14, 2018
Targeting Cyclin D-CDK4/6 Sensitizes Immune-Refractory Cancer by Blocking the SCP3-NANOG AxisSe Jin Oh, Hanbyoul Cho, Suhyun Kim, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|May 5, 2020
Smoking, Smoking Cessation, and Progression of Chronic Kidney Disease: Results From KNOW-CKD StudySangmi Lee, Shinchan Kang, Young Su Joo, et al.
Oncotarget|September 30, 2015
Proton pump inhibitors enhance the effects of cytotoxic agents in chemoresistant epithelial ovarian carcinomaYoo-Young Lee, Hye-Kyung Jeon, Ji Eun Hong, et al.
Radiology|January 27, 2026
Establishing CT-derived Normative Liver and Spleen Volumes for Children: Validation in Regional and International DatasetsJae-Yeon Hwang, Young Hun Choi, Ah Young Jung, et al.
Pageof 91